Otsuka et al., 1991 - Google Patents
Pentobarbital produces dissimilar changes in glucose influx and utilization in brainOtsuka et al., 1991
- Document ID
- 571478788870163885
- Author
- Otsuka T
- Wei L
- Bereczki D
- Acuff V
- Patlak C
- Fenstermacher J
- Publication year
- Publication venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
External Links
Snippet
The effects of pentobarbital sodium on local cerebral glucose utilization (LCGU) and 3-O- methylglucose (3-MG) influx were measured by quantitative autoradiography in 52 brain areas of control and treated rats. Pentobarbital (50 mg/kg ip) lowered LCGU to a relatively …
- 229960001412 Pentobarbital 0 title abstract description 75
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1206—Administration of radioactive gases, aerosols or breath tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Otsuka et al. | Pentobarbital produces dissimilar changes in glucose influx and utilization in brain | |
| Fenstermacher et al. | Methods for quantifying the transport of drugs across brain barrier systems | |
| Bereczki et al. | Hypercapnia slightly raises blood volume and sizably elevates flow velocity in brain microvessels | |
| Wise et al. | Serial observations on the pathophysiology of acute stroke: the transition from ischaemia to infarction as reflected in regional oxygen extraction | |
| Kiszka-Kanowitz et al. | Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique | |
| Jarden et al. | Positron emission tomographic measurement of blood‐to‐brain and blood‐to‐tumor transport of 82Rb: The effect of dexamethasone and whole‐brain radiation therapy | |
| Cornford et al. | Developmental modulations of blood-brain barrier permeability as an indicator of changing nutritional requirements in the brain | |
| Henriksen | Evidence suggestive of diffuse brain damage following cardiac operations | |
| Foster et al. | Comparison of microspheres and 86Rb+ as tracers of the distribution of cardiac output in rats indicates invalidity of 86Rb+-based measurements | |
| Wei et al. | The velocities of red cell and plasma flows through parenchymal microvessels of rat brain are decreased by pentobarbital | |
| Aldrich et al. | Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia | |
| Chen et al. | Nicotine raises the influx of permeable solutes across the rat blood—brain barrier with little or no capillary recruitment | |
| Taytard et al. | Platelet kinetics in stable atopic asthmatic patients | |
| Forsyth et al. | Redistribution of cardiac output after sodium pentobarbital anesthesia in the monkey | |
| Tyson et al. | Cerebrovascular permeability following MCA occlusion in the rat: The effect of halothane-induced hypotension | |
| Otsuka et al. | Variation in local cerebral blood flow response to high-dose pentobarbital sodium in the rat | |
| Junck et al. | Effects of xenon and krypton on regional cerebral blood flow in the rat | |
| Whitsett et al. | The effect of hepatic blood flow on the hepatic removal rate of oxyphenbutazone in the dog | |
| Pasternak et al. | Regional cerebral blood flow in the newborn beagle pup: the germinal matrix is a “low-flow” structure | |
| Schaible et al. | High-dose pentobarbital pharmacokinetics in hypothermic brain-injured children | |
| Chen et al. | Slightly Altered Permeability—Surface Area Products Imply Some Cerebral Capillary Recruitment during Hypercapnia | |
| EP1304124B1 (en) | Diagnostic agent for diabetes comprising 13C labelled compound | |
| Horton et al. | Regional cerebral blood flow in the rat as determined by particle distribution and by diffusible tracer. | |
| Furman et al. | Morphine pharmacokinetics during anesthesia and surgery in patients with burns | |
| Nakagawa et al. | Dexamethasone effects on vascular volume and tissue hematocrit in experimental RG-2 gliomas and adjacent brain |